Engineers Gate Manager’s iBio IBIO Stock Holding History

Engineers Gate Manager’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-96	Closed	-$26K	–	2054
2021 Q4	$26K	Buy	+96	New	+$36.6K	﹤0.01%	1925
2021 Q2	–	Sell	-21	Closed	-$16K	–	1791
2021 Q1	$16K	Buy	+21	New	+$18.3K	﹤0.01%	1767

Other funds holding IBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Engineers Gate Manager's IBIO Position: Q1 2022 in Review

Engineers Gate Manager sold out of iBio (IBIO) in Q1 2022, closing a stake of 96 shares — an estimated $26K sold.

Engineers Gate Manager first reported a position in IBIO in Q1 2021 and held it in 2 quarters. The position peaked at $26K in Q4 2021. 70 funds tracked by Wall St. Rank hold IBIO as of Q1 2022.

Engineers Gate Manager reported no remaining iBio position as of Q1 2022 after selling out during the quarter.
Engineers Gate Manager sold 96 iBio shares in Q1 2022, an estimated $26K.
Engineers Gate Manager first reported a position in iBio in Q1 2021 and held it in 2 quarters.
Engineers Gate Manager's iBio position peaked at $26K in Q4 2021.
70 funds tracked by Wall St. Rank held iBio as of Q1 2022.

Based on Engineers Gate Manager's 13F filing for Q1 2022, filed 16 May 2022.